Clinical Trial: Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use Disorders

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07737652) titled 'Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use Disorders' on July 27.

Brief Summary: The goal of this clinical trial is to learn whether adding Microcurrent Neurofeedback (MCN) to standard residential treatment helps adults with substance use disorder more than standard treatment alone. It will also learn whether MCN is feasible to deliver in a residential treatment setting. The main questions it aims to answer are:

Does adding MCN to Standard Care reduce substance cravings more than Standard Care alone? Does adding MCN to Standard Care reduce symptoms of depression, anxiety, and PTSD more than Standard...